MetaADEDB 2.0 @ LMMD
Thiethylperazine
(XCTYLCDETUVOIP-UHFFFAOYSA-N)
Structure
SMILES
CCSc1ccc2c(c1)N(CCCN1CCN(CC1)C)c1c(S2)cccc1
Type(s)
Approved; Withdrawn
ATC code(s)
R06AD03
Molecular Formula:
C22H29N3S2
Molecular Weight:
399.616
Log P:
4.9796
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
60.32
CAS Number(s):
1179-69-7; 1420-55-9
Synonym(s)
1.
Thiethylperazine
2.
Norzine
3.
Thiethylperazine Malate
4.
Thiethylperazine Maleate (2:1)
5.
Torecan
External Link(s)
MeSHD013847
PubChem Compound5440
BindingDB50339132
78436
ChEBI9544
CHEMBLCHEMBL1378
DrugBankDB00372
DrugCentral2630
IUPHAR/BPS Guide to PHARMACOLOGY7306
KEGGcpd:C07132
dr:D02354
Therapeutic Target DatabaseD0Y0ER
ZINC22446674
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 4US FAERS
2NauseaFAERS: 4
Canada Vigilance: 1
514725CTD
OFFSIDES
Canada Vigilance
US FAERS
3SomnolenceFAERS: 4US FAERS
4TachycardiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
5ThirstFAERS: 4US FAERS
6DystoniaFAERS: 3
Canada Vigilance: 1

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
7DysarthriaFAERS: 2US FAERS
8Excessive eye blinkingFAERS: 2OFFSIDES
US FAERS
9Hypoaesthesia facialFAERS: 2OFFSIDES
US FAERS
10ScotomaFAERS: 2OFFSIDES
US FAERS
11TorticollisFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
12TremorFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
13AstheniaFAERS: 1US FAERS
14BradykinesiaFAERS: 1US FAERS
15Drug administration errorFAERS: 1US FAERS
16DysphoniaFAERS: 1US FAERS
17HyperpyrexiaFAERS: 1US FAERS
18HypersensitivityFAERS: 1US FAERS
19LaryngospasmFAERS: 1OFFSIDES
US FAERS
20Muscle RigidityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
21OculogyrationFAERS: 1US FAERS
22Oculogyric crisisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
23PainFAERS: 1OFFSIDES
US FAERS
24Parkinsonian crisisFAERS: 1US FAERS
25Tardive DyskinesiaFAERS: 1OFFSIDES
US FAERS
26Abdominal PainCanada Vigilance: 1Canada Vigilance
27AcidosisOFFSIDES
28AgitationCanada Vigilance: 1Canada Vigilance
29AmnesiaOFFSIDES
30AmphetaminesOFFSIDES
31Angioedema16101941CTD
32AnhedoniaOFFSIDES
33AnxietyCanada Vigilance: 1Canada Vigilance
OFFSIDES
34Aortic AneurysmOFFSIDES
35Aphthous StomatitisOFFSIDES
36ArteriosclerosisOFFSIDES
37AscitesOFFSIDES
38AsthmaOFFSIDES
39Basal Ganglia Diseases875594
8084830
16101941
CTD
40Benign Prostatic HyperplasiaOFFSIDES
41Blood GlucoseOFFSIDES
42Blood creatine phosphokinase MB increasedOFFSIDES
43Blood creatine phosphokinase increasedOFFSIDES
44Blood glucose fluctuationOFFSIDES
45Blood phosphorus decreasedOFFSIDES
46Blood sodiumOFFSIDES
47Bone lesionOFFSIDES
48BronchitisOFFSIDES
49BruxismOFFSIDES
50Cataract operationOFFSIDES
51CataractOFFSIDES
52CellulitisOFFSIDES
53Central venous catheter removalOFFSIDES
54Choking sensationOFFSIDES
55Chronic Obstructive Airway DiseaseOFFSIDES
56Cleft Palate12742335CTD
57ColectomyOFFSIDES
58Colon adenomaOFFSIDES
59Compression fractureOFFSIDES
60ContractureOFFSIDES
61DeafnessOFFSIDES
62DebridementOFFSIDES
63Deglutition Disorders16101941CTD
64Denervation atrophyOFFSIDES
65Dental abscessOFFSIDES
66Dental cariesOFFSIDES
67Denture wearerOFFSIDES
68DiabetesOFFSIDES
69Diarrhea9348575CTD
70DiplopiaCanada Vigilance: 1Canada Vigilance
71DiverticulosisOFFSIDES
72DrowsinessOFFSIDES
73Drug Overdose4184863CTD
74Dyskinesia, Drug-Induced8084830
16101941
CTD
75DysphemiaOFFSIDES
76Ejection Fraction DecreasedOFFSIDES
77Endodontic procedureOFFSIDES
78Erythema MultiformeOFFSIDES
79Erythema16101941CTD
80Feeling jitteryCanada Vigilance: 1Canada Vigilance
81General physical health deteriorationOFFSIDES
82GlobulinuriaOFFSIDES
83Graft infectionOFFSIDES
84GranulocytosisOFFSIDES
85Hospice CareOFFSIDES
86Intention tremorOFFSIDES
87Kidney FailureOFFSIDES
88Leukopenia neonatalOFFSIDES
89Malignant neoplasm progressionOFFSIDES
90Mastication disorderOFFSIDES
91Mental status changesOFFSIDES
92Migraine Disorders4184863CTD
93Mouth Abnormalities17328645CTD
94Musculoskeletal PainOFFSIDES
95Musculoskeletal discomfortOFFSIDES
96Musculoskeletal stiffnessCanada Vigilance: 1Canada Vigilance
97Myeloma recurrenceOFFSIDES
98Myoclonus2475196CTD
99NephrolithiasisOFFSIDES
100Nerve BlockOFFSIDES
101NeurodermatitisOFFSIDES
102OpisthotonusCanada Vigilance: 2Canada Vigilance
103OsteoporosisOFFSIDES
104OsteosclerosisOFFSIDES
105Parkinsonian Disorders15469457CTD
106Renal cystOFFSIDES
107Respiratory FailureOFFSIDES
108RestlessnessCanada Vigilance: 1Canada Vigilance
109RetrocollisOFFSIDES
110RhabdomyolysisOFFSIDES
111SinusitisOFFSIDES
112Skin lacerationOFFSIDES
113Skin toxicityOFFSIDES
114Speech Disorders16101941CTD
115StrabismusCanada Vigilance: 1Canada Vigilance
116StuporCanada Vigilance: 1Canada Vigilance
117Supraventricular tachycardiaCanada Vigilance: 1Canada Vigilance
118TendinitisOFFSIDES
119TetanyCanada Vigilance: 1Canada Vigilance
120Tongue movement disturbanceCanada Vigilance: 1Canada Vigilance
121Tooth ExtractionOFFSIDES
122UrticariaCanada Vigilance: 1Canada Vigilance
123Vascular insufficiencyOFFSIDES
124Vomiting514725
7147262
CTD
125anaphylaxis16101941CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.